Learn More
BACKGROUND Limited treatments are available for persistent erythema of rosacea. OBJECTIVE To examine the long-term safety and efficacy of oxymetazoline cream 1.0% in patients with rosacea with(More)
BACKGROUND Bimatoprost ophthalmic solution 0.03% was approved in the US for reducing intraoccular pressure (IOP) based on two double-masked, active-controlled clinical trials. Four additional(More)
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be(More)